PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
6 hedge funds and large institutions have $2.32M invested in PureTech Health in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
24% more capital invested
Capital invested by funds: $1.87M → $2.32M (+$449K)
20% more funds holding
Funds holding: 5 → 6 (+1)
0.01% more ownership
Funds ownership: 0.16% → 0.16% (+0.01%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$217K |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$173K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$34.4K |
| 2 |
Millennium Management
New York
|
-$6.45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $860K | -$6.45K | -353 | -0.8% |
|
|
PCM
2
Pentwater Capital Management
Naples,
Florida
| $664K | +$173K | +9,449 | +39% |
|
|
BHIA
3
Birch Hill Investment Advisors
Boston,
Massachusetts
| $560K | – | – | – |
|
|
PCM
4
Portolan Capital Management
Boston,
Massachusetts
| $235K | +$217K | +11,885 | New |
|
5
Morgan Stanley
New York
| $1.98K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $396 | -$34.4K | -1,883 | -99% |
|
PRTC Hedge Fund Activity: Q1 2025 in Review
6 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q1 2025, worth a combined $2.32M — up 24% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PRTC positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Portolan Capital Management, opening a new position worth an estimated $217K. The largest seller was UBS Group, cutting an estimated $34.4K.
- 6 institutional investors held PureTech Health (PRTC) as of Q1 2025, up from 5 in Q4 2024.
- Funds reported $2.32M of PureTech Health stock for Q1 2025, up 24% quarter-over-quarter.
- 1 fund opened new PureTech Health positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest PureTech Health buyer in Q1 2025 was Portolan Capital Management, an estimated $217K added.
- The largest PureTech Health seller in Q1 2025 was UBS Group, an estimated $34.4K sold.
Based on aggregated 13F filings for Q1 2025.